National Institute on Drug Abuse; Notice of Closed Meeting, 50545-50546 [2021-19408]

Download as PDF 50545 Federal Register / Vol. 86, No. 172 / Thursday, September 9, 2021 / Notices the proposed collection of information is necessary for the proper performance of FDA’s functions, including whether the information will have practical utility; (2) the accuracy of FDA’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology. Generic Clearance for Quantitative Testing for the Development of FDA Communications OMB Control Number 0910–0865— Extension This notice requests extension of OMB approval of the FDA information collection for a generic clearance that allows FDA to use quantitative social/ behavioral science data collection techniques (i.e., surveys and experimental studies) to test consumers’ reactions to FDA communications or educational messaging about FDAregulated food and cosmetic products, dietary supplements, and animal food and feed. To ensure that communications activities and educational campaigns have the highest potential to be received, understood, and accepted by those for whom they are intended, it is important to assess communications while they are under development. Understanding consumers’ attitudes, motivations, and behaviors in response to potential communications and education messaging plays an important role in improving FDA’s communications. If the following conditions are not met, FDA will submit an information collection request to OMB for approval through the normal PRA process: • The collections are voluntary; • The collections are low burden for participants (based on considerations of total burden hours, total number of participants, or burden hours per participant) and are low cost for both the participants and the Federal Government; • The collections are noncontroversial; • Personally-identifiable information (PII) is collected only to the extent necessary 1 and is not retained; • Information gathered will not be used for the purpose of substantially informing influential policy decisions; 2 and • Information gathered will yield qualitative findings; the collections will not be designed or expected to yield statistical data or used as though the results are generalizable to the population of study. To obtain approval for an individual generic collection submission that meets the conditions of this generic clearance, an abbreviated supporting statement will be submitted to OMB along with supporting documentation (e.g., a copy of the survey or experimental design and stimuli for testing). FDA will submit individual quantitative collections under this generic clearance to OMB. Individual quantitative collections will also undergo review by FDA’s Research Involving Human Subjects Committee, senior leadership in the Center for Food Safety and Applied Nutrition, and PRA specialists. Respondents to this collection of information may include a wide range of consumers and other FDA stakeholders such as producers and manufacturers who are regulated under FDA-regulated food and cosmetic products, dietary supplements, and animal food and feed. We estimate the burden of this collection of information as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN BY ANTICIPATED DATA COLLECTION METHODS 1 Average burden per response Total annual disclosures Total hours Cognitive Interviews Screener .............................. Cognitive Interviews .............................................. Pre-test Study Screener ....................................... Pre-test Study ....................................................... Self-administered Surveys/Experimental Studies Screener. Self-administered Surveys/Experimental Studies 720 144 2,400 480 75,000 1 1 1 1 1 720 144 2,400 480 75,000 0.083 (5 minutes) ......... 1 .................................... 0.083 (5 minutes) ......... 0.25 (15 minutes) ......... 0.083 (5 minutes) ......... 60 144 199 120 6,225 15,000 1 15,000 0.25 (15 minutes) ......... 3,750 Total ............................................................... ........................ ........................ ........................ ....................................... 10,498 1 There lotter on DSK11XQN23PROD with NOTICES1 Number of disclosures per respondent Number of respondents Survey type are no capital costs or operating and maintenance costs associated with this collection of information. Based on a review of the information collection since our last request for OMB approval, we have made no adjustments to our burden estimate. The total estimated annual burden is 10,498 hours. Current estimates are based on both historical numbers of participants from past projects as well as estimates for projects to be conducted in the next 3 years. The number of participants to be included in each new survey will Dated: September 3, 2021. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. 1 For example, collections that collect PII to provide remuneration for participants of focus groups and cognitive laboratory studies will be submitted under this request. All Privacy Act requirements will be met. 2 As defined in OMB and Agency Information Quality Guidelines, ‘‘influential’’ means that ‘‘an agency can reasonably determine that dissemination of the information will have or does have a clear and substantial impact on important VerDate Sep<11>2014 19:38 Sep 08, 2021 Jkt 253001 vary, depending on the nature of the compliance efforts and the target audience. [FR Doc. 2021–19480 Filed 9–8–21; 8:45 am] BILLING CODE 4164–01–P PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as public policies or important private sector decisions.’’ E:\FR\FM\09SEN1.SGM 09SEN1 50546 Federal Register / Vol. 86, No. 172 / Thursday, September 9, 2021 / Notices amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed). Date: October 18, 2021. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 402–7371, yvonne.ferguson@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: September 2, 2021. Tyeshia Roberson-Curtis, Program Analyst, Office Federal Advisory Committee Policy. [FR Doc. 2021–19408 Filed 9–8–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard lotter on DSK11XQN23PROD with NOTICES1 [Docket No. USCG–2021–0408] Guidance: Change 3 to NVIC 24–14 Guidelines on Qualification for STCW Endorsements as Electro-Technical Rating on Vessels Powered by Main Propulsion Machinery of 750 KW/1,000 HP or More Coast Guard, DHS. Notice of availability. AGENCY: ACTION: VerDate Sep<11>2014 19:38 Sep 08, 2021 Jkt 253001 The Coast Guard announces the availability of Change 3 to Navigation and Vessel Inspection Circular (NVIC) 24–14: Guidelines on Qualification for STCW Endorsements as Electro-Technical Rating (ETR) on Vessels Powered by Main Propulsion Machinery of 750 kW/1,000 HP or More. This NVIC provides guidance to mariners concerning STCW endorsements for ETR, including training and qualifications. This change notice revises NVIC 24–14 to indicate that the Coast Guard will allow mariners to qualify for an STCW endorsement as ETR without completing approved training for high voltage systems or computer systems and maintenance. DATES: The policies announced in Change-3 to NVIC 24–14 are effective as of August 26, 2021. ADDRESSES: To view documents mentioned in this notice, search the docket number USCG–2021–0408 using the Federal eRulemaking Portal at https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: For information about this document, contact James Cavo, Mariner Credentialing Program Policy Division (CG–MMC–2), Coast Guard; telephone 202–372–1205; email MMCPolicy@ uscg.mil. SUPPLEMENTARY INFORMATION: The Coast Guard will use NVIC 24–14 and 46 CFR part 12 to establish whether mariners are qualified to hold STCW rating endorsements as Electro-Technical Rating (ETR) on Vessels Powered by Main Propulsion Machinery of 750 kW/ 1,000 HP or More. As specified in 46 CFR 12.611, mariners seeking this endorsement must complete an approved training for High Voltage Systems and Computer Systems and Maintenance. The standards of competence requirements for STCW endorsements as ETR are found in Table A–III/7 of the STCW Code. That STCW table does not include standards of competence relevant to high voltage systems or computer systems and maintenance. The Coast Guard will not enforce the requirement for approved courses in Computer Systems and Maintenance or High Voltage Systems for an ETR endorsement because it places a higher training burden on U.S. mariners compared to what is required of the international maritime workforce for a similar endorsement. The time and cost for a mariner to complete these courses outweighs any benefit the course would provide because the mariner does not use this knowledge and proficiency in their ETR capacity. Therefore, we have determined this training requirement SUMMARY: PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 goes beyond the skillset necessary and the level of responsibility associated with an ETR endorsement, and thus is unnecessary and overly burdensome. For these reasons, this Commandant Change Notice will allow mariners to qualify for an STCW endorsement as ETR without completing approved training for computer systems and maintenance and for high voltage power systems. The approved High Voltage Power Systems training courses will still be required and utilized for the ElectroTechnical Officer endorsement. This notice is issued under authority of 5 U.S.C. 552(a). Dated: September 2, 2021. J.W. Mauger, Rear Admiral, U.S. Coast Guard, Assistant Commandant for Prevention Policy. [FR Doc. 2021–19411 Filed 9–8–21; 8:45 am] BILLING CODE 9110–04–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2020–0278] Port Access Route Study: Northern New York Bight Coast Guard, Homeland Security (DHS). ACTION: Notice of availability of draft report; reopening of the comment period. AGENCY: The U.S. Coast Guard is reopening the comment period to further its outreach efforts and solicit additional comments concerning its Northern New York Bight Port Access Route Study (NNYBPARS) draft version of the study report. DATES: Your comments and related material must reach the Coast Guard on or before September 30, 2021. ADDRESSES: You may submit comments identified by docket number USCG– 2020–0278 using the Federal portal at https://www.regulations.gov. See the ‘‘Public Participation and Request for Comments’’ portion of the SUPPLEMENTARY INFORMATION section for further instructions on submitting comments. SUMMARY: If you have questions on this notice, contact Mr. Craig Lapiejko, Waterways Management at First Coast Guard District, telephone (617) 223–8351, email craig.d.lapiejko@uscg.mil. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: E:\FR\FM\09SEN1.SGM 09SEN1

Agencies

[Federal Register Volume 86, Number 172 (Thursday, September 9, 2021)]
[Notices]
[Pages 50545-50546]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19408]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 50546]]

amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Single Cell Opioid Responses in the Context of HIV 
(SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, 
Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not 
Allowed).
    Date: October 18, 2021.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, NIH, 301 
North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 402-
7371, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: September 2, 2021.
Tyeshia Roberson-Curtis,
Program Analyst, Office Federal Advisory Committee Policy.
[FR Doc. 2021-19408 Filed 9-8-21; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.